Alpha Cognition Inc. - Common Stock (NQ:ACOG)

9.100 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Alpha Cognition Inc. - Common Stock

< Previous 1 2 3 Next >

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 02, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces CONVERGE Real-World Evidence on ZUNVEYL®(Benzgalantamine) Use in Long-Term Care

October 01, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 09, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 01, 2026

From Alpha Cognition Inc.

Via Business Wire

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26

August 17, 2026

Dallas, Texas--(Newsfile Corp. - August 17, 2026) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on...

Via Newsfile

Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update

August 13, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Report Second Quarter 2026 Financial Results and Provide Business Update

August 03, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Receives European Patent Covering ZUNVEYL® for the Treatment of Mild-to-Moderate Alzheimer’s Disease

July 29, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Participate in Panel Discussion at the B. Riley Securities Mind, Muscle & Vision Summit

July 10, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board

June 23, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces First Patient Enrolled in RESOLVE Phase 4 Study Evaluating ZUNVEYL® in Patients with Mild to Moderate Alzheimer’s Disease

June 16, 2026

From Alpha Cognition, Inc.

Via Business Wire

Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease

June 09, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update

May 14, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026

April 28, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Inc. to Participate in Three Upcoming Investor Conferences

April 27, 2026

From Alpha Cognition, Inc.

Via Business Wire

Alpha Cognition Strengthens Its Board of Directors with Appointment of Bethany Sensenig

April 20, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 15, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury

April 01, 2026

From Alpha Cognition Inc.

Via Business Wire

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425

April 01, 2026

Dallas, Texas--(Newsfile Corp. - April 1, 2026) - Alpha Cognition Inc. (NASDAQ: ACOG): Stonegate Capital Partners updates their coverage on...

Via Newsfile

Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update

March 26, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition (Nasdaq: ACOG) to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, March 26, 2026

March 13, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition to Present New Clinical on ZUNVEYL® (Benzgalantamine) at Multiple Upcoming Alzheimer’s Association International Conferences

March 10, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study

February 25, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens

February 18, 2026

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution

January 07, 2026

From Alpha Cognition, Inc.

Via Business Wire

Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners

December 01, 2025

From Alpha Cognition Inc.

Via Business Wire

Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q3 2025

November 14, 2025

Dallas, Texas--(Newsfile Corp. - November 14, 2025) - Alpha...

Via Newsfile

Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update

November 13, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025

October 30, 2025

From Alpha Cognition Inc.

Via Business Wire

Alpha Cognition, Inc. to Present at Spartan Capital Securities' Second Annual Investor Conference

October 15, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.